Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
This completed trial evaluated controlled ovarian hyperstimulation using letrozole with gonadotropin in infertility patients, with implicati…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC [Phase 2]
Phase 2 trial evaluating the combination of letrozole and trastuzumab (Herceptin) in HER2-positive, ER/PR-positive metastatic breast cancer …
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating Herceptin (trastuzumab) in women with metastatic breast cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers [Phase 1]
Phase 1 study of MM-111 in advanced, refractory HER2-amplified, heregulin-positive cancers has completed and results were posted.
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer [Phase 1]
A completed Phase 1 trial evaluating defined green tea catechin extract in women with hormone receptor-negative breast cancer (Stage I-III).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors [Phase 1]
This document provides a Phase 1 clinical trial update on using Interleukin-12 to treat various hematologic cancers and solid tumors; the st…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating lapatinib in combination with everolimus for advanced triple-negative breast cancer was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Preoperative Oral Dexamethasone to Improve Recovery After Surgery [Phase 2]
A Phase 2 clinical trial evaluating whether preoperative oral dexamethasone improves recovery after breast cancer surgery. The study is spon…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer [Phase 1]
Phase 1 trial of a cancer vaccine therapy in patients with advanced or metastatic cancers has completed, spanning multiple indications.
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer [Phase 2]
Phase 2 clinical trial update for vorinostat as treatment in women undergoing surgery for newly diagnosed stage I–III breast cancer; status …
-
CLINICAL_TRIALS research · 2014-09-08Clinical Trial Update: The Impact of a Patient Education Intervention for Ambulatory Oncology Patients [NA]
A completed clinical trial evaluating the impact of a patient education intervention for ambulatory oncology patients across multiple cancer…
-
CLINICAL_TRIALS research · 2014-09-03Clinical Trial Update: Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin [Phase 2]
A Phase 2 trial evaluating paclitaxel in combination with liposomal doxorubicin for metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer [Phase 2]
Phase 2 trial results for lapatinib in chemotherapy-naive or metastatic breast cancer were reported in this update.
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy [Phase 2]
A Phase 2 clinical trial update reports results for partial breast irradiation using accelerated intensity-modulated radiotherapy in breast …
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Nurse-led Care Program for Cancer Patients in Chemotherapy Day Center [NA]
This study update describes a nurse-led care program for cancer patients in a chemotherapy day center, conducted by The Hong Kong Polytechni…
-
CLINICAL_TRIALS research · 2014-08-27Clinical Trial Update: Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer [NA]
A clinical trial update describing the investigation of weekly liposomal paclitaxel plus cisplatin as a preoperative treatment for breast ca…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. [Phase 2]
Phase II study of a dose-dense AC regimen (fluorouracil, epirubicin, cyclophosphamide) with filgrastim support, followed by weekly paclitaxe…
-
FDA approval · 2014-08-25FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) from AstraZeneca Pharmaceuticals, resulting in an updated label follo…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Lymphedema Prevention in Breast Cancer [NA]
The clinical trial update notes the completed status of a study investigating lymphedema prevention in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery [Phase 2]
Phase 2 trial evaluating pegylated liposomal doxorubicin with docetaxel in locally advanced breast cancer that could be removed by surgery; …
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment [Phase 3]
Phase 3 trial update for afatinib (BIBW 2992) in HER2-positive metastatic breast cancer after one prior Herceptin treatment completes; resul…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib [Phase 3]
Phase 3 trial for ErbB2-overexpressing metastatic breast cancer using paclitaxel, trastuzumab, and lapatinib; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer [Phase 2]
A Phase 2 randomized trial compared ramucirumab plus eribulin to eribulin alone in breast cancer. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts [NA]
A completed Mayo Clinic trial evaluated low-dose molecular breast imaging as a screening tool for women with dense breasts; results were pos…
-
CLINICAL_TRIALS research · 2014-08-19Clinical Trial Update: OctavaPink for Women With Dense Breast After Negative Mammography
Clinical trial update on OctavaPink for women with dense breast tissue after a negative mammogram; the current trial status is UNKNOWN.